Valeant Pharmaceuticals International Inc (NYSE:VRX)

205.32
Delayed Data
As of Apr 17
 -2.04 / -0.98%
Today’s Change
106.00
Today|||52-Week Range
211.57
+43.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line159.6M-116.0M-863.7M912.2M
 
 
 
 
 
Depreciation612.6M986.2M1.4B1.7B
 
 
 
 
 
Total Other Cash Flow264.4M359.3M1.4B319.1M
 
 
 
 
 
Funds From Operations813.6M909.9M1.4B3.0B
 
 
 
 
 
Funds From/For Other Operating Expenses137.1M253.3M378.3M668.4M
 
 
 
 
 
Net Cash Flow - Operating Activities676.5M656.6M1.0B2.3B
 
 
 
 
 
 
InvestingIncrease In Investments-81.1M-7.2M0.00-147.9M
 
 
 
 
Decrease In Investments86.6M624.8M17.0M129.1M
 
 
 
 
 
Capital Expenditures-58.5M-107.6M-115.3M-291.6M
 
 
 
 
 
Fixed Asset Disposal0.0092.0M41.1M1.5B
 
 
 
 
Net Assets From Acquisitions -2.5B-3.5B-5.3B-1.1B
 
 
 
 
 
Other Investing - Uses0.00-8.9M0.000.00
 
 
Net Cash Flow Investing-2.8B-3.0B-5.4B-99.7M
 
 
 
 
 
 
FinancingShort Term Borrowings--4.3M-47.7M-9.0M
 
 
 
 
Long Term Borrowings5.3B6.0B8.3B1.6B
 
 
 
 
 
Long Term Debt Reduction-2.6B-1.9B-6.3B-3.9B
 
 
 
 
 
Net Proceeds Stock Sale41.7M23.0M2.3B17.2M
 
 
 
 
 
Common Preferred Redeemed-639.2M-280.7M-55.6M0.00
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing26.5M12.5M24.2M17.1M
 
 
 
 
 
Other Uses - Financing210.9M741.3M197.7M158.4M
 
 
 
 
 
Net Cash Flow - Financing1.9B3.1B4.0B-2.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-10.3M3.8M-5.1M-29.0M
 
 
 
 
 
 
Net Change In Cash-219.9M748.2M-310.7M-248.7M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account